nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—MMP2—testicular cancer	0.699	1	CbGaD
Captopril—REN—posterior vena cava—testicular cancer	0.0254	0.259	CbGeAlD
Captopril—F2—posterior vena cava—testicular cancer	0.0177	0.181	CbGeAlD
Captopril—ABCB1—Dactinomycin—testicular cancer	0.013	0.166	CbGbCtD
Captopril—REN—vein—testicular cancer	0.0112	0.114	CbGeAlD
Captopril—SLC22A6—Methotrexate—testicular cancer	0.0109	0.139	CbGbCtD
Captopril—ALB—Methotrexate—testicular cancer	0.00925	0.118	CbGbCtD
Captopril—ABCB1—Vinblastine—testicular cancer	0.00813	0.104	CbGbCtD
Captopril—F2—vein—testicular cancer	0.00782	0.0798	CbGeAlD
Captopril—CYP2D6—Vinblastine—testicular cancer	0.00766	0.0979	CbGbCtD
Captopril—ABCB1—Cisplatin—testicular cancer	0.00745	0.0953	CbGbCtD
Captopril—ABCB1—Etoposide—testicular cancer	0.00732	0.0936	CbGbCtD
Captopril—ABCB1—Doxorubicin—testicular cancer	0.00499	0.0639	CbGbCtD
Captopril—ABCB1—Methotrexate—testicular cancer	0.00484	0.0619	CbGbCtD
Captopril—ACE—vein—testicular cancer	0.00478	0.0487	CbGeAlD
Captopril—CYP2D6—Doxorubicin—testicular cancer	0.00471	0.0602	CbGbCtD
Captopril—LTA4H—embryo—testicular cancer	0.00275	0.028	CbGeAlD
Captopril—LTA4H—seminal vesicle—testicular cancer	0.00258	0.0263	CbGeAlD
Captopril—MMP2—embryo—testicular cancer	0.00195	0.0199	CbGeAlD
Captopril—LTA4H—gonad—testicular cancer	0.00187	0.019	CbGeAlD
Captopril—MMP2—seminal vesicle—testicular cancer	0.00183	0.0187	CbGeAlD
Captopril—MMP9—embryo—testicular cancer	0.0017	0.0173	CbGeAlD
Captopril—LTA4H—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00158	0.167	CbGpPWpGaD
Captopril—LTA4H—female gonad—testicular cancer	0.00152	0.0155	CbGeAlD
Captopril—LTA4H—testis—testicular cancer	0.00135	0.0137	CbGeAlD
Captopril—MMP2—gonad—testicular cancer	0.00132	0.0135	CbGeAlD
Captopril—REN—female gonad—testicular cancer	0.00117	0.0119	CbGeAlD
Captopril—MMP2—female gonad—testicular cancer	0.00108	0.011	CbGeAlD
Captopril—LTA4H—lymph node—testicular cancer	0.000975	0.00994	CbGeAlD
Captopril—MMP2—testis—testicular cancer	0.000955	0.00973	CbGeAlD
Captopril—MMP9—female gonad—testicular cancer	0.000936	0.00955	CbGeAlD
Captopril—ACE—embryo—testicular cancer	0.000905	0.00922	CbGeAlD
Captopril—ACE—seminal vesicle—testicular cancer	0.00085	0.00866	CbGeAlD
Captopril—MMP9—testis—testicular cancer	0.00083	0.00847	CbGeAlD
Captopril—F2—female gonad—testicular cancer	0.000817	0.00833	CbGeAlD
Captopril—MMP2—lymph node—testicular cancer	0.000692	0.00706	CbGeAlD
Captopril—ACE—gonad—testicular cancer	0.000614	0.00626	CbGeAlD
Captopril—MMP9—lymph node—testicular cancer	0.000602	0.00614	CbGeAlD
Captopril—ACE—female gonad—testicular cancer	0.000499	0.00509	CbGeAlD
Captopril—ALB—testis—testicular cancer	0.000462	0.00471	CbGeAlD
Captopril—ACE—testis—testicular cancer	0.000443	0.00451	CbGeAlD
Captopril—MMP2—Syndecan-2-mediated signaling events—FGFR3—testicular cancer	0.000423	0.0447	CbGpPWpGaD
Captopril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000408	0.0431	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—PRDM14—testicular cancer	0.000352	0.0372	CbGpPWpGaD
Captopril—ALB—lymph node—testicular cancer	0.000335	0.00342	CbGeAlD
Captopril—ACE—lymph node—testicular cancer	0.000321	0.00327	CbGeAlD
Captopril—ABCB1—embryo—testicular cancer	0.000318	0.00325	CbGeAlD
Captopril—ABCB1—seminal vesicle—testicular cancer	0.000299	0.00305	CbGeAlD
Captopril—F2—Regulation of IGF Activity by IGFBP—MMP2—testicular cancer	0.000268	0.0283	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—FGFR3—testicular cancer	0.000265	0.0281	CbGpPWpGaD
Captopril—MMP9—Matrix Metalloproteinases—MMP2—testicular cancer	0.000261	0.0276	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—INSL3—testicular cancer	0.000258	0.0273	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—MMP2—testicular cancer	0.000254	0.0269	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00025	0.0264	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—MMP2—testicular cancer	0.000248	0.0262	CbGpPWpGaD
Captopril—MMP9—Activation of Matrix Metalloproteinases—MMP2—testicular cancer	0.000248	0.0262	CbGpPWpGaD
Captopril—CYP2D6—female gonad—testicular cancer	0.000244	0.00249	CbGeAlD
Captopril—MMP9—Developmental Biology—PRDM14—testicular cancer	0.000231	0.0244	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000226	0.0239	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000221	0.0233	CbGpPWpGaD
Captopril—CYP2D6—testis—testicular cancer	0.000217	0.00221	CbGeAlD
Captopril—ABCB1—gonad—testicular cancer	0.000216	0.0022	CbGeAlD
Captopril—MMP9—Collagen degradation—MMP2—testicular cancer	0.000216	0.0228	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—MMP2—testicular cancer	0.000203	0.0215	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—FGFR3—testicular cancer	0.0002	0.0212	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000185	0.0196	CbGpPWpGaD
Captopril—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—testicular cancer	0.000179	0.0189	CbGpPWpGaD
Captopril—ABCB1—female gonad—testicular cancer	0.000176	0.00179	CbGeAlD
Captopril—MMP9—Endochondral Ossification—FGFR3—testicular cancer	0.000175	0.0185	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000173	0.0183	CbGpPWpGaD
Captopril—ABCB1—testis—testicular cancer	0.000156	0.00159	CbGeAlD
Captopril—MMP9—LPA receptor mediated events—MMP2—testicular cancer	0.000142	0.015	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—MMP2—testicular cancer	0.000139	0.0147	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—testicular cancer	0.000134	0.0142	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—INSL3—testicular cancer	0.000132	0.014	CbGpPWpGaD
Captopril—Asthenia—Bleomycin—testicular cancer	0.000131	0.00114	CcSEcCtD
Captopril—Hyponatraemia—Doxorubicin—testicular cancer	0.000131	0.00114	CcSEcCtD
Captopril—Pruritus—Bleomycin—testicular cancer	0.00013	0.00112	CcSEcCtD
Captopril—Feeling abnormal—Ifosfamide—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Chest pain—Etoposide—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Nausea—Vinblastine—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Orthostatic hypotension—Epirubicin—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Anorexia—Cisplatin—testicular cancer	0.000129	0.00112	CcSEcCtD
Captopril—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000128	0.00111	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—testicular cancer	0.000128	0.00111	CcSEcCtD
Captopril—Discomfort—Etoposide—testicular cancer	0.000127	0.00111	CcSEcCtD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000127	0.0134	CbGpPWpGaD
Captopril—Hypotension—Cisplatin—testicular cancer	0.000126	0.00109	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—KITLG—testicular cancer	0.000125	0.0132	CbGpPWpGaD
Captopril—Confusional state—Etoposide—testicular cancer	0.000125	0.00108	CcSEcCtD
Captopril—Muscular weakness—Epirubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—testicular cancer	0.000124	0.00108	CcSEcCtD
Captopril—Abdominal pain—Ifosfamide—testicular cancer	0.000124	0.00107	CcSEcCtD
Captopril—Body temperature increased—Ifosfamide—testicular cancer	0.000124	0.00107	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—testicular cancer	0.000124	0.00107	CcSEcCtD
Captopril—Anaphylactic shock—Etoposide—testicular cancer	0.000124	0.00107	CcSEcCtD
Captopril—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000123	0.00107	CcSEcCtD
Captopril—Ataxia—Doxorubicin—testicular cancer	0.000123	0.00106	CcSEcCtD
Captopril—Asthenia—Dactinomycin—testicular cancer	0.000123	0.00106	CcSEcCtD
Captopril—Neutropenia—Methotrexate—testicular cancer	0.000122	0.00106	CcSEcCtD
Captopril—Paraesthesia—Cisplatin—testicular cancer	0.000121	0.00105	CcSEcCtD
Captopril—Thrombocytopenia—Etoposide—testicular cancer	0.000121	0.00105	CcSEcCtD
Captopril—Tachycardia—Etoposide—testicular cancer	0.000121	0.00105	CcSEcCtD
Captopril—Eosinophilia—Epirubicin—testicular cancer	0.000121	0.00105	CcSEcCtD
Captopril—Dyspnoea—Cisplatin—testicular cancer	0.00012	0.00104	CcSEcCtD
Captopril—Erectile dysfunction—Methotrexate—testicular cancer	0.00012	0.00104	CcSEcCtD
Captopril—Pancreatitis—Epirubicin—testicular cancer	0.00012	0.00104	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000119	0.00103	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.000119	0.0126	CbGpPWpGaD
Captopril—Photosensitivity reaction—Methotrexate—testicular cancer	0.000119	0.00103	CcSEcCtD
Captopril—Angina pectoris—Epirubicin—testicular cancer	0.000119	0.00103	CcSEcCtD
Captopril—Anorexia—Etoposide—testicular cancer	0.000118	0.00102	CcSEcCtD
Captopril—Decreased appetite—Cisplatin—testicular cancer	0.000117	0.00102	CcSEcCtD
Captopril—Diarrhoea—Dactinomycin—testicular cancer	0.000117	0.00101	CcSEcCtD
Captopril—Vomiting—Bleomycin—testicular cancer	0.000117	0.00101	CcSEcCtD
Captopril—Pancytopenia—Epirubicin—testicular cancer	0.000116	0.001	CcSEcCtD
Captopril—Hypotension—Etoposide—testicular cancer	0.000116	0.001	CcSEcCtD
Captopril—Rash—Bleomycin—testicular cancer	0.000116	0.001	CcSEcCtD
Captopril—Dermatitis—Bleomycin—testicular cancer	0.000115	0.001	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000115	0.000998	CcSEcCtD
Captopril—Muscular weakness—Doxorubicin—testicular cancer	0.000115	0.000998	CcSEcCtD
Captopril—Renal failure—Methotrexate—testicular cancer	0.000114	0.00099	CcSEcCtD
Captopril—Neutropenia—Epirubicin—testicular cancer	0.000114	0.000988	CcSEcCtD
Captopril—Stomatitis—Methotrexate—testicular cancer	0.000113	0.000982	CcSEcCtD
Captopril—ABCB1—lymph node—testicular cancer	0.000113	0.00115	CbGeAlD
Captopril—Pollakiuria—Epirubicin—testicular cancer	0.000113	0.000976	CcSEcCtD
Captopril—Asthenia—Ifosfamide—testicular cancer	0.000112	0.000974	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—testicular cancer	0.000112	0.000968	CcSEcCtD
Captopril—Photosensitivity reaction—Epirubicin—testicular cancer	0.000111	0.000965	CcSEcCtD
Captopril—Feeling abnormal—Cisplatin—testicular cancer	0.000111	0.000965	CcSEcCtD
Captopril—Paraesthesia—Etoposide—testicular cancer	0.000111	0.000963	CcSEcCtD
Captopril—Pruritus—Ifosfamide—testicular cancer	0.000111	0.000961	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—testicular cancer	0.000111	0.000959	CcSEcCtD
Captopril—Weight decreased—Epirubicin—testicular cancer	0.00011	0.000956	CcSEcCtD
Captopril—Dyspnoea—Etoposide—testicular cancer	0.00011	0.000956	CcSEcCtD
Captopril—Somnolence—Etoposide—testicular cancer	0.00011	0.000953	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—testicular cancer	0.00011	0.000953	CcSEcCtD
Captopril—MMP9—Degradation of the extracellular matrix—MMP2—testicular cancer	0.000109	0.0116	CbGpPWpGaD
Captopril—Nausea—Bleomycin—testicular cancer	0.000109	0.000944	CcSEcCtD
Captopril—Vomiting—Dactinomycin—testicular cancer	0.000109	0.000942	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—testicular cancer	0.000108	0.00094	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000108	0.000934	CcSEcCtD
Captopril—Rash—Dactinomycin—testicular cancer	0.000108	0.000934	CcSEcCtD
Captopril—Decreased appetite—Etoposide—testicular cancer	0.000108	0.000932	CcSEcCtD
Captopril—Diarrhoea—Ifosfamide—testicular cancer	0.000107	0.000929	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—testicular cancer	0.000107	0.000929	CcSEcCtD
Captopril—Renal failure—Epirubicin—testicular cancer	0.000107	0.000926	CcSEcCtD
Captopril—Body temperature increased—Cisplatin—testicular cancer	0.000107	0.000925	CcSEcCtD
Captopril—Fatigue—Etoposide—testicular cancer	0.000107	0.000925	CcSEcCtD
Captopril—Stomatitis—Epirubicin—testicular cancer	0.000106	0.000919	CcSEcCtD
Captopril—Jaundice—Epirubicin—testicular cancer	0.000106	0.000919	CcSEcCtD
Captopril—Constipation—Etoposide—testicular cancer	0.000106	0.000917	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—testicular cancer	0.000105	0.000915	CcSEcCtD
Captopril—MMP9—EPH-Ephrin signaling—MMP2—testicular cancer	0.000105	0.0111	CbGpPWpGaD
Captopril—Hepatitis—Methotrexate—testicular cancer	0.000104	0.000904	CcSEcCtD
Captopril—Pollakiuria—Doxorubicin—testicular cancer	0.000104	0.000903	CcSEcCtD
Captopril—Dizziness—Ifosfamide—testicular cancer	0.000104	0.000898	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—testicular cancer	0.000104	0.000897	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000103	0.000893	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—testicular cancer	0.000102	0.000885	CcSEcCtD
Captopril—Feeling abnormal—Etoposide—testicular cancer	0.000102	0.000884	CcSEcCtD
Captopril—Nausea—Dactinomycin—testicular cancer	0.000102	0.00088	CcSEcCtD
Captopril—Agranulocytosis—Epirubicin—testicular cancer	0.000101	0.00088	CcSEcCtD
Captopril—Gastrointestinal pain—Etoposide—testicular cancer	0.000101	0.000877	CcSEcCtD
Captopril—LTA4H—Metabolism—HPGDS—testicular cancer	0.000101	0.0106	CbGpPWpGaD
Captopril—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	9.97e-05	0.000865	CcSEcCtD
Captopril—Vomiting—Ifosfamide—testicular cancer	9.96e-05	0.000863	CcSEcCtD
Captopril—Renal failure—Doxorubicin—testicular cancer	9.89e-05	0.000857	CcSEcCtD
Captopril—Rash—Ifosfamide—testicular cancer	9.87e-05	0.000856	CcSEcCtD
Captopril—Dermatitis—Ifosfamide—testicular cancer	9.87e-05	0.000855	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—testicular cancer	9.86e-05	0.000855	CcSEcCtD
Captopril—Jaundice—Doxorubicin—testicular cancer	9.81e-05	0.00085	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—testicular cancer	9.81e-05	0.00085	CcSEcCtD
Captopril—Rhinitis—Epirubicin—testicular cancer	9.78e-05	0.000848	CcSEcCtD
Captopril—Body temperature increased—Etoposide—testicular cancer	9.78e-05	0.000848	CcSEcCtD
Captopril—Abdominal pain—Etoposide—testicular cancer	9.78e-05	0.000848	CcSEcCtD
Captopril—Hepatitis—Epirubicin—testicular cancer	9.76e-05	0.000846	CcSEcCtD
Captopril—Asthenia—Cisplatin—testicular cancer	9.69e-05	0.00084	CcSEcCtD
Captopril—Pharyngitis—Epirubicin—testicular cancer	9.69e-05	0.00084	CcSEcCtD
Captopril—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	9.63e-05	0.0102	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	9.41e-05	0.00995	CbGpPWpGaD
Captopril—Agranulocytosis—Doxorubicin—testicular cancer	9.39e-05	0.000814	CcSEcCtD
Captopril—Nausea—Ifosfamide—testicular cancer	9.3e-05	0.000806	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—FGFR3—testicular cancer	9.3e-05	0.00983	CbGpPWpGaD
Captopril—Diarrhoea—Cisplatin—testicular cancer	9.24e-05	0.000801	CcSEcCtD
Captopril—Erythema multiforme—Epirubicin—testicular cancer	9.23e-05	0.0008	CcSEcCtD
Captopril—Alopecia—Methotrexate—testicular cancer	9.22e-05	0.000799	CcSEcCtD
Captopril—Flushing—Epirubicin—testicular cancer	9.06e-05	0.000785	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—testicular cancer	9.05e-05	0.000785	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—testicular cancer	9.03e-05	0.000783	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—testicular cancer	8.96e-05	0.000777	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—testicular cancer	8.89e-05	0.000771	CcSEcCtD
Captopril—Asthenia—Etoposide—testicular cancer	8.87e-05	0.000769	CcSEcCtD
Captopril—Pruritus—Etoposide—testicular cancer	8.75e-05	0.000759	CcSEcCtD
Captopril—Alopecia—Epirubicin—testicular cancer	8.62e-05	0.000748	CcSEcCtD
Captopril—Vomiting—Cisplatin—testicular cancer	8.58e-05	0.000744	CcSEcCtD
Captopril—Vision blurred—Methotrexate—testicular cancer	8.56e-05	0.000742	CcSEcCtD
Captopril—MMP9—Signaling by SCF-KIT—KIT—testicular cancer	8.54e-05	0.00903	CbGpPWpGaD
Captopril—Erythema multiforme—Doxorubicin—testicular cancer	8.54e-05	0.00074	CcSEcCtD
Captopril—Rash—Cisplatin—testicular cancer	8.51e-05	0.000738	CcSEcCtD
Captopril—Dermatitis—Cisplatin—testicular cancer	8.51e-05	0.000737	CcSEcCtD
Captopril—Diarrhoea—Etoposide—testicular cancer	8.46e-05	0.000734	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—testicular cancer	8.42e-05	0.00073	CcSEcCtD
Captopril—Anaemia—Methotrexate—testicular cancer	8.39e-05	0.000727	CcSEcCtD
Captopril—Flushing—Doxorubicin—testicular cancer	8.38e-05	0.000727	CcSEcCtD
Captopril—Tension—Epirubicin—testicular cancer	8.34e-05	0.000723	CcSEcCtD
Captopril—Dysgeusia—Epirubicin—testicular cancer	8.32e-05	0.000721	CcSEcCtD
Captopril—Nervousness—Epirubicin—testicular cancer	8.25e-05	0.000715	CcSEcCtD
Captopril—Malaise—Methotrexate—testicular cancer	8.19e-05	0.00071	CcSEcCtD
Captopril—Dizziness—Etoposide—testicular cancer	8.18e-05	0.000709	CcSEcCtD
Captopril—Nausea—Cisplatin—testicular cancer	8.02e-05	0.000695	CcSEcCtD
Captopril—Vision blurred—Epirubicin—testicular cancer	8.01e-05	0.000694	CcSEcCtD
Captopril—Alopecia—Doxorubicin—testicular cancer	7.98e-05	0.000692	CcSEcCtD
Captopril—Cough—Methotrexate—testicular cancer	7.92e-05	0.000687	CcSEcCtD
Captopril—Ill-defined disorder—Epirubicin—testicular cancer	7.88e-05	0.000683	CcSEcCtD
Captopril—Vomiting—Etoposide—testicular cancer	7.86e-05	0.000682	CcSEcCtD
Captopril—Anaemia—Epirubicin—testicular cancer	7.85e-05	0.000681	CcSEcCtD
Captopril—Rash—Etoposide—testicular cancer	7.8e-05	0.000676	CcSEcCtD
Captopril—Dermatitis—Etoposide—testicular cancer	7.79e-05	0.000675	CcSEcCtD
Captopril—Headache—Etoposide—testicular cancer	7.75e-05	0.000672	CcSEcCtD
Captopril—Arthralgia—Methotrexate—testicular cancer	7.73e-05	0.00067	CcSEcCtD
Captopril—Myalgia—Methotrexate—testicular cancer	7.73e-05	0.00067	CcSEcCtD
Captopril—Chest pain—Methotrexate—testicular cancer	7.73e-05	0.00067	CcSEcCtD
Captopril—Tension—Doxorubicin—testicular cancer	7.71e-05	0.000669	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—testicular cancer	7.7e-05	0.000667	CcSEcCtD
Captopril—Malaise—Epirubicin—testicular cancer	7.66e-05	0.000664	CcSEcCtD
Captopril—Discomfort—Methotrexate—testicular cancer	7.64e-05	0.000662	CcSEcCtD
Captopril—Nervousness—Doxorubicin—testicular cancer	7.63e-05	0.000662	CcSEcCtD
Captopril—Syncope—Epirubicin—testicular cancer	7.62e-05	0.00066	CcSEcCtD
Captopril—Palpitations—Epirubicin—testicular cancer	7.51e-05	0.000651	CcSEcCtD
Captopril—Confusional state—Methotrexate—testicular cancer	7.47e-05	0.000648	CcSEcCtD
Captopril—Loss of consciousness—Epirubicin—testicular cancer	7.47e-05	0.000647	CcSEcCtD
Captopril—F2—GPCR downstream signaling—INSL3—testicular cancer	7.46e-05	0.00789	CbGpPWpGaD
Captopril—Cough—Epirubicin—testicular cancer	7.41e-05	0.000643	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—testicular cancer	7.41e-05	0.000642	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—testicular cancer	7.41e-05	0.000642	CcSEcCtD
Captopril—Nausea—Etoposide—testicular cancer	7.35e-05	0.000637	CcSEcCtD
Captopril—LTA4H—Metabolism—STK11—testicular cancer	7.31e-05	0.00772	CbGpPWpGaD
Captopril—Ill-defined disorder—Doxorubicin—testicular cancer	7.29e-05	0.000632	CcSEcCtD
Captopril—Anaemia—Doxorubicin—testicular cancer	7.27e-05	0.00063	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—testicular cancer	7.25e-05	0.000629	CcSEcCtD
Captopril—Myalgia—Epirubicin—testicular cancer	7.23e-05	0.000627	CcSEcCtD
Captopril—Chest pain—Epirubicin—testicular cancer	7.23e-05	0.000627	CcSEcCtD
Captopril—Arthralgia—Epirubicin—testicular cancer	7.23e-05	0.000627	CcSEcCtD
Captopril—Discomfort—Epirubicin—testicular cancer	7.15e-05	0.00062	CcSEcCtD
Captopril—Malaise—Doxorubicin—testicular cancer	7.09e-05	0.000615	CcSEcCtD
Captopril—Dry mouth—Epirubicin—testicular cancer	7.07e-05	0.000613	CcSEcCtD
Captopril—Anorexia—Methotrexate—testicular cancer	7.06e-05	0.000612	CcSEcCtD
Captopril—Syncope—Doxorubicin—testicular cancer	7.05e-05	0.000611	CcSEcCtD
Captopril—Confusional state—Epirubicin—testicular cancer	6.99e-05	0.000606	CcSEcCtD
Captopril—Palpitations—Doxorubicin—testicular cancer	6.95e-05	0.000602	CcSEcCtD
Captopril—Anaphylactic shock—Epirubicin—testicular cancer	6.93e-05	0.000601	CcSEcCtD
Captopril—Hypotension—Methotrexate—testicular cancer	6.92e-05	0.0006	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—testicular cancer	6.91e-05	0.000599	CcSEcCtD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	6.87e-05	0.00726	CbGpPWpGaD
Captopril—Cough—Doxorubicin—testicular cancer	6.86e-05	0.000595	CcSEcCtD
Captopril—Shock—Epirubicin—testicular cancer	6.82e-05	0.000591	CcSEcCtD
Captopril—Thrombocytopenia—Epirubicin—testicular cancer	6.79e-05	0.000589	CcSEcCtD
Captopril—F2—Signaling by GPCR—INSL3—testicular cancer	6.77e-05	0.00716	CbGpPWpGaD
Captopril—Tachycardia—Epirubicin—testicular cancer	6.77e-05	0.000587	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.75e-05	0.000585	CcSEcCtD
Captopril—Insomnia—Methotrexate—testicular cancer	6.7e-05	0.000581	CcSEcCtD
Captopril—Myalgia—Doxorubicin—testicular cancer	6.69e-05	0.00058	CcSEcCtD
Captopril—Chest pain—Doxorubicin—testicular cancer	6.69e-05	0.00058	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—testicular cancer	6.69e-05	0.00058	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—testicular cancer	6.65e-05	0.000577	CcSEcCtD
Captopril—Discomfort—Doxorubicin—testicular cancer	6.61e-05	0.000573	CcSEcCtD
Captopril—Anorexia—Epirubicin—testicular cancer	6.61e-05	0.000573	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—testicular cancer	6.61e-05	0.000573	CcSEcCtD
Captopril—Somnolence—Methotrexate—testicular cancer	6.59e-05	0.000571	CcSEcCtD
Captopril—REN—Metabolism of proteins—MMP2—testicular cancer	6.57e-05	0.00695	CbGpPWpGaD
Captopril—Dry mouth—Doxorubicin—testicular cancer	6.55e-05	0.000567	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—testicular cancer	6.52e-05	0.000565	CcSEcCtD
Captopril—Hypotension—Epirubicin—testicular cancer	6.48e-05	0.000562	CcSEcCtD
Captopril—Confusional state—Doxorubicin—testicular cancer	6.47e-05	0.000561	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—testicular cancer	6.44e-05	0.000558	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—testicular cancer	6.42e-05	0.000556	CcSEcCtD
Captopril—Fatigue—Methotrexate—testicular cancer	6.39e-05	0.000554	CcSEcCtD
Captopril—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.32e-05	0.000548	CcSEcCtD
Captopril—Shock—Doxorubicin—testicular cancer	6.31e-05	0.000547	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—testicular cancer	6.28e-05	0.000545	CcSEcCtD
Captopril—Insomnia—Epirubicin—testicular cancer	6.27e-05	0.000544	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—testicular cancer	6.26e-05	0.000543	CcSEcCtD
Captopril—Paraesthesia—Epirubicin—testicular cancer	6.23e-05	0.00054	CcSEcCtD
Captopril—Dyspnoea—Epirubicin—testicular cancer	6.18e-05	0.000536	CcSEcCtD
Captopril—Somnolence—Epirubicin—testicular cancer	6.16e-05	0.000534	CcSEcCtD
Captopril—Anorexia—Doxorubicin—testicular cancer	6.12e-05	0.00053	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—testicular cancer	6.11e-05	0.000529	CcSEcCtD
Captopril—Dyspepsia—Epirubicin—testicular cancer	6.1e-05	0.000529	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—testicular cancer	6.06e-05	0.000525	CcSEcCtD
Captopril—Decreased appetite—Epirubicin—testicular cancer	6.03e-05	0.000523	CcSEcCtD
Captopril—Hypotension—Doxorubicin—testicular cancer	5.99e-05	0.00052	CcSEcCtD
Captopril—Fatigue—Epirubicin—testicular cancer	5.98e-05	0.000518	CcSEcCtD
Captopril—Constipation—Epirubicin—testicular cancer	5.93e-05	0.000514	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—testicular cancer	5.86e-05	0.000508	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—testicular cancer	5.86e-05	0.000508	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.85e-05	0.000507	CcSEcCtD
Captopril—Insomnia—Doxorubicin—testicular cancer	5.8e-05	0.000503	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—testicular cancer	5.76e-05	0.000499	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—testicular cancer	5.72e-05	0.000496	CcSEcCtD
Captopril—Feeling abnormal—Epirubicin—testicular cancer	5.71e-05	0.000495	CcSEcCtD
Captopril—Somnolence—Doxorubicin—testicular cancer	5.7e-05	0.000494	CcSEcCtD
Captopril—Gastrointestinal pain—Epirubicin—testicular cancer	5.67e-05	0.000492	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—testicular cancer	5.65e-05	0.00049	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—testicular cancer	5.58e-05	0.000483	CcSEcCtD
Captopril—Fatigue—Doxorubicin—testicular cancer	5.53e-05	0.00048	CcSEcCtD
Captopril—Constipation—Doxorubicin—testicular cancer	5.49e-05	0.000476	CcSEcCtD
Captopril—Abdominal pain—Epirubicin—testicular cancer	5.48e-05	0.000475	CcSEcCtD
Captopril—Body temperature increased—Epirubicin—testicular cancer	5.48e-05	0.000475	CcSEcCtD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	5.34e-05	0.00564	CbGpPWpGaD
Captopril—Asthenia—Methotrexate—testicular cancer	5.32e-05	0.000461	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—testicular cancer	5.29e-05	0.000458	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—testicular cancer	5.25e-05	0.000455	CcSEcCtD
Captopril—Pruritus—Methotrexate—testicular cancer	5.24e-05	0.000454	CcSEcCtD
Captopril—MMP9—Signaling Pathways—INSL3—testicular cancer	5.18e-05	0.00548	CbGpPWpGaD
Captopril—Body temperature increased—Doxorubicin—testicular cancer	5.07e-05	0.00044	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—testicular cancer	5.07e-05	0.00044	CcSEcCtD
Captopril—Diarrhoea—Methotrexate—testicular cancer	5.07e-05	0.000439	CcSEcCtD
Captopril—Asthenia—Epirubicin—testicular cancer	4.97e-05	0.000431	CcSEcCtD
Captopril—Pruritus—Epirubicin—testicular cancer	4.91e-05	0.000425	CcSEcCtD
Captopril—Dizziness—Methotrexate—testicular cancer	4.9e-05	0.000425	CcSEcCtD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.89e-05	0.00517	CbGpPWpGaD
Captopril—Diarrhoea—Epirubicin—testicular cancer	4.74e-05	0.000411	CcSEcCtD
Captopril—Vomiting—Methotrexate—testicular cancer	4.71e-05	0.000408	CcSEcCtD
Captopril—Rash—Methotrexate—testicular cancer	4.67e-05	0.000405	CcSEcCtD
Captopril—Dermatitis—Methotrexate—testicular cancer	4.67e-05	0.000405	CcSEcCtD
Captopril—Headache—Methotrexate—testicular cancer	4.64e-05	0.000402	CcSEcCtD
Captopril—Asthenia—Doxorubicin—testicular cancer	4.6e-05	0.000399	CcSEcCtD
Captopril—Dizziness—Epirubicin—testicular cancer	4.59e-05	0.000397	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—MMP2—testicular cancer	4.58e-05	0.00484	CbGpPWpGaD
Captopril—Pruritus—Doxorubicin—testicular cancer	4.54e-05	0.000393	CcSEcCtD
Captopril—Vomiting—Epirubicin—testicular cancer	4.41e-05	0.000382	CcSEcCtD
Captopril—Nausea—Methotrexate—testicular cancer	4.4e-05	0.000382	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—testicular cancer	4.39e-05	0.000381	CcSEcCtD
Captopril—Rash—Epirubicin—testicular cancer	4.37e-05	0.000379	CcSEcCtD
Captopril—Dermatitis—Epirubicin—testicular cancer	4.37e-05	0.000379	CcSEcCtD
Captopril—Headache—Epirubicin—testicular cancer	4.34e-05	0.000377	CcSEcCtD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.29e-05	0.00453	CbGpPWpGaD
Captopril—Dizziness—Doxorubicin—testicular cancer	4.24e-05	0.000368	CcSEcCtD
Captopril—Nausea—Epirubicin—testicular cancer	4.12e-05	0.000357	CcSEcCtD
Captopril—Vomiting—Doxorubicin—testicular cancer	4.08e-05	0.000354	CcSEcCtD
Captopril—Rash—Doxorubicin—testicular cancer	4.05e-05	0.000351	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—testicular cancer	4.04e-05	0.00035	CcSEcCtD
Captopril—Headache—Doxorubicin—testicular cancer	4.02e-05	0.000348	CcSEcCtD
Captopril—CYP2D6—Biological oxidations—HPGDS—testicular cancer	4.02e-05	0.00425	CbGpPWpGaD
Captopril—F2—Signaling Pathways—INSL3—testicular cancer	4e-05	0.00423	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	3.92e-05	0.00414	CbGpPWpGaD
Captopril—MMP9—Axon guidance—MMP2—testicular cancer	3.89e-05	0.00411	CbGpPWpGaD
Captopril—Nausea—Doxorubicin—testicular cancer	3.81e-05	0.00033	CcSEcCtD
Captopril—ACE—Metabolism of proteins—MMP2—testicular cancer	2.94e-05	0.0031	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	2.85e-05	0.00301	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MMP2—testicular cancer	2.78e-05	0.00293	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.87e-05	0.00197	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—H2AFZ—testicular cancer	1.66e-05	0.00175	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—MMP2—testicular cancer	1.65e-05	0.00175	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STK11—testicular cancer	1.65e-05	0.00174	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KITLG—testicular cancer	1.53e-05	0.00161	CbGpPWpGaD
Captopril—F2—Signaling Pathways—H2AFZ—testicular cancer	1.28e-05	0.00135	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STK11—testicular cancer	1.27e-05	0.00135	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KITLG—testicular cancer	1.18e-05	0.00125	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FGFR3—testicular cancer	1.13e-05	0.0012	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KIT—testicular cancer	1.04e-05	0.0011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FGFR3—testicular cancer	8.76e-06	0.000926	CbGpPWpGaD
Captopril—ALB—Metabolism—HPGDS—testicular cancer	8.32e-06	0.000879	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KIT—testicular cancer	8.04e-06	0.00085	CbGpPWpGaD
Captopril—ABCB1—Metabolism—HPGDS—testicular cancer	7.29e-06	0.000771	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—HPGDS—testicular cancer	6.87e-06	0.000726	CbGpPWpGaD
Captopril—ALB—Metabolism—STK11—testicular cancer	6.04e-06	0.000639	CbGpPWpGaD
Captopril—ABCB1—Metabolism—STK11—testicular cancer	5.3e-06	0.00056	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—STK11—testicular cancer	4.99e-06	0.000528	CbGpPWpGaD
